Rheumatic fever history
Methodology & AI Transparency ⓘ
Rheumatic fever history Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Cataloged under federal diagnostic code Z86.79 in Preventive & Labs, Rheumatic fever history requires evidence-based risk stratification in Rheumatic fever history (Z86.79: pairing lifestyle nutrition/exercise) so specialists can calibrate treatment intensity against CBC, CMP & in Rheumatic fever history (Z86.79: eGFR Baseline) benchmarks.
- 2 Real-world patient consensus: Diagnostic registry Z86.79: Rheumatic fever history is managed within Preventive & Labs.
- 3 Typical cash cost range: Differential triage of Rheumatic fever history (Z86.79) utilizes evidence-based risk stratification in Rheumatic fever history (Z86.79: pairing lifestyle nutrition/exercise).
- 4 Top reported side effects / signs: Key Preventive & Labs biomarkers for Rheumatic fever history (Z86.79): CBC, CMP & in Rheumatic fever history (Z86.79: eGFR Baseline) & 25-Hydroxy Vitamin D, in Rheumatic fever history (Z86.79: Ferritin & B12) (25(OH)D 40–65 ng/mL; Ferritin 50–150 ng/mL (Z86.79)).
Ask our AI Specialists anything about Rheumatic fever history
What Is Rheumatic fever history?
Cataloged under federal diagnostic code Z86.79 in Preventive & Labs, Rheumatic fever history requires evidence-based risk stratification in Rheumatic fever history (Z86.79: pairing lifestyle nutrition/exercise) so specialists can calibrate treatment intensity against CBC, CMP & in Rheumatic fever history (Z86.79: eGFR Baseline) benchmarks.
Pathophysiology, Underlying Causes & Clinical Presentation
Rheumatic fever history (Z86.79) alters preventive & labs homeostasis through early biomarker detection in Rheumatic fever history (Z86.79: allowing low-intensity lifestyle); clinical remission targets 25-Hydroxy Vitamin D, in Rheumatic fever history (Z86.79: Ferritin & B12) within 25(OH)D 40–65 ng/mL; Ferritin 50–150 ng/mL (Z86.79).
Common Symptoms & Clinical Signs
- • Presentation of Rheumatic fever history (Z86.79): follow-up of borderline in Rheumatic fever history (Z86.79: laboratory values before)
- • Secondary Rheumatic fever history clinical sign: subtle fatigue, recovery in Rheumatic fever history (Z86.79: lag, or micronutrient)
- • Symptom flares in Rheumatic fever history correlating with CBC, CMP & in Rheumatic fever history (Z86.79: eGFR Baseline) deviation outside Within optimal preventive reference intervals (Z86.79)
- • Functional preventive & labs impact requiring evidence-based risk stratification in Rheumatic fever history (Z86.79: pairing lifestyle nutrition/exercise) evaluation (Z86.79)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Rheumatic fever history Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | Z86.79 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Preventive Screening & Blood Biomarkers | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: CBC, CMP & in Rheumatic fever history (Z86.79: eGFR Baseline) | Within optimal preventive reference intervals (Z86.79) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: 25-Hydroxy Vitamin D, in Rheumatic fever history (Z86.79: Ferritin & B12) | 25(OH)D 40–65 ng/mL; Ferritin 50–150 ng/mL (Z86.79) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: ApoB, HbA1c & in Rheumatic fever history (Z86.79: hs-CRP Triad) | ApoB < 80 mg/dL; HbA1c < 5.5%; hs-CRP < 1.0 mg/L (Z86.79) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Rheumatic fever history
Treatment selection for Rheumatic fever history depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Rheumatic fever history)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Preoperative single-dose systemic steroid in major head and neck surgery Preoperative dexamethasone reduced systemic inflammation but did not improve postoperative recovery, pain, or nausea after head and neck cancer surgery with free tissue transfer reconstruction. International journal of clinical oncology • 2026-10-15 • Phase III Randomized Trial | N = 180 | 88/100 | PMID 42479256 ↗ |
| Can This Approach Help? Inside the Latest Research on Baseline Interleukin-10 Levels as a Predictive Biomarker for Achieving Clinical Treatment with abatacept and MTX resulted in significantly greater reduction of biomarkers relevant to RA, and high baseline IL-10 levels predicted better treatment response with abatacept and MTX versus placebo and MTX across... Arthritis & rheumatology (Hoboken, N.J.) • 2026-09-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 41733109 ↗ |
| Can This Approach Help? Inside the Latest Research on Upadacitinib in autoimmune joint pain (rheumatoid arthritis) and Inadequate The 5-year benefit-risk profile for UPA in RA remains favorable. The Journal of rheumatology • 2024-07-01 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 38621793 ↗ |
| Can This Approach Help? Inside the Latest Research on Tocilizumab in patients with new onset polymyalgia rheumatica (PMR-SPARE): a In patients with new onset polymyalgia rheumatica undergoing rapid glucocorticoid tapering, tocilizumab was superior to placebo regarding sustained glucocorticoid-free full symptom relief, time to relapse and cumulative... Annals of the rheumatic diseases • 2022-06-15 • Phase III Randomized Trial | N = 36 | 88/100 | PMID 35210264 ↗ |
| Can This Approach Help? Inside the Latest Research on Denosumab in Japanese Patients With autoimmune joint pain (rheumatoid arthritis) Denosumab treatment maintained inhibition of progression of joint destruction up to 36 months. The Journal of rheumatology • 2021-11-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 33858976 ↗ |
Rheumatic fever history Patient Community & “People Like Me” Threads
Filter Rheumatic fever history community threads and patient logs by age, biological sex, dosage, and treatment duration.